ConvaTec Group Plc Stock
Stocks
CTEC
GB00BD3VFW73
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
London S.E.
11:35:06 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 212.00 GBX | +1.24% |
|
-0.93% | -12.83% |
| 09-28 | Convatec Launches Cure Aqua? In The United States And Canada | CI |
| 09-23 | Bernstein Keeps ConvaTec Group Rating at Outperform | MT |
| Market Cap | 5.49B 4.83B 4.57B 4.14B 7.78B 527B 7.83B 54.58B 21.08B 269B 20.62B 20.17B 865B | P/E 2026 * |
21.8x | P/E 2027 * | 15x |
|---|---|---|---|---|---|
| Enterprise Value | 6.9B 6.06B 5.74B 5.2B 9.77B 662B 9.83B 68.52B 26.47B 338B 25.89B 25.33B 1,085B | EV / Sales 2026 * |
2.7x | EV / Sales 2027 * | 2.46x |
| Free-Float |
95.11% | Yield 2026 * |
2.83% | Yield 2027 * | 3.23% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| CTEC | Delayed | |
CBOE
| CTEC | Real-time | |
|
Berne S.E.
| 2CV | End-of-day quote | |
|
OTC Markets
| CNVVF | Delayed | |
|
Deutsche Boerse AG
| 2CV | Delayed | |
|
Tradegate
| 2CV | Real-time | |
|
Börse Stuttgart
| 2CV | Delayed | |
|
Boerse Muenchen
| 2CV | Real-time |
Last Transcript: ConvaTec Group Plc
| 1 day | +1.24% | ||
| 1 week | -0.93% | ||
| Current month | -6.85% | ||
| 1 month | -7.67% | ||
| 3 months | +0.19% | ||
| 6 months | -3.02% | ||
| Current year | -12.83% |
| 1 week | 209.2 |  | 217.2 |
| 1 month | 209.2 | | 235.4 |
| Current year | 193 | | 259.3 |
| 1 year | 193 | | 259.3 |
| 3 years | 193 | | 311.2 |
| 5 years | 165.3 | | 311.2 |
| 10 years | 113.25 | | 349.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Mason
CEO | Chief Executive Officer | 62 | 2025-08-03 |
Fiona Ryder
DFI | Director of Finance/CFO | 51 | 2025-08-03 |
Peter Jarvis
COO | Chief Operating Officer | - | 2026-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Margaret Ewing
BRD | Director/Board Member | 71 | 2017-08-13 |
John McAdam
CHM | Chairman | 78 | 2019-09-29 |
Brian May
BRD | Director/Board Member | 62 | 2020-03-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/26/26 | Buy | Chief Executive Officer | 50,000 | 0.0026% | ||
| 5/26/26 | Buy | Chief Financial Officer | 24,993 | 0.0013% | ||
| 3/17/26 | Exercice | Chief Executive Officer | 106,137 | 0.0054% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.24% | -0.93% | -5.86% | -2.57% | 5.42B | |
| -0.31% | -1.59% | -24.39% | +5.71% | 175B | |
| +0.97% | -2.85% | -5.01% | +14.42% | 113B | |
| -1.01% | -1.61% | -1.04% | +64.08% | 58.57B | |
| +0.01% | +1.60% | -0.42% | -28.97% | 50.07B | |
| +0.45% | +4.36% | +15.64% | +53.13% | 49.92B | |
| +0.07% | -2.99% | +29.18% | -5.87% | 32.69B | |
| +1.07% | +10.84% | - | - | 30.44B | |
| +1.41% | +3.68% | +43.64% | +0.13% | 26.07B | |
| +1.98% | +9.34% | +26.26% | -2.43% | 23.55B | |
| Average | +0.47% | +1.37% | +8.67% | +10.85% | 56.54B | |
| Weighted average by Cap. | +0.01% | -0.01% | -2.74% | +13.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.55B 2.25B 2.12B 1.93B 3.62B 245B 3.64B 25.39B 9.81B 125B 9.59B 9.38B 402B | 2.73B 2.4B 2.27B 2.06B 3.87B 262B 3.89B 27.16B 10.49B 134B 10.26B 10.04B 430B |
| Net income | 250M 220M 208M 189M 354M 23.98B 356M 2.48B 959M 12.24B 938M 918M 39.33B | 364M 320M 303M 275M 516M 34.97B 519M 3.62B 1.4B 17.85B 1.37B 1.34B 57.35B |
| Net Debt | 1.4B 1.23B 1.17B 1.06B 1.99B 135B 2B 13.94B 5.38B 68.7B 5.27B 5.15B 221B | 1.22B 1.08B 1.02B 923M 1.73B 117B 1.74B 12.16B 4.7B 59.94B 4.59B 4.49B 193B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | GBX 212.00 | +1.24% | 4,600,254 |
| 26-09-25 | GBX 209.40 | -1.04% | 5,845,117 |
| 26-09-24 | GBX 211.60 | -1.40% | 6,563,436 |
| 26-09-23 | GBX 214.60 | -0.28% | 3,436,107 |
| 26-09-22 | GBX 215.20 | +0.19% | 4,176,035 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CTEC Stock
Select your edition
All financial news and data tailored to specific country editions
